Dr. Tushar Pawar has a decade of experience in the surgical management of multiple cancers, such as gastrointestinal cancers, thoracic cancers, gynaecological cancers, urological cancers, breast cancer, soft tissue cancers and head and neck cancers.
He is well-versed in multivisceral resections and minimally invasive approaches.
Dr. Tushar's primary interest lies in GI oncology and minimally-invasive GI oncosurgery, and his secondary interest lies in abdominopelvic malignancies and breast cancers.
He has handled more than 1000 cases so far.
Training and Certifications
Dr. Tushar has completed his advanced fellowship training in minimally invasive surgery (laparoscopic and robotic), cytoreductive surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC) for gastrointestinal cancers.
Dr. Tushar is a member of various national and international, surgical oncology and medical associations.
His research articles have been published in indexed national and international medical journals.
Colorectal Services in Covid-19 Times: Minimally Invasive Surgery and Enhanced Recovery, the Need of the Hour. Indian J Surg Oncol. 2020 Oct 14;11(Suppl 2):1-5.
Laparoscopic supralevator posterior exenteration in a case of previous laparoscopic ovarian transposition - a video vignette. Colorectal Dis. 2020 Oct;22(10):1470-1471.
The Technique and Justification for Minimally Invasive Surgery in COVID-19 Pandemic: Laparoscopic Anterior Resection for Near Obstructed Rectal Carcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A, vol. 30, no. 5, 2020, pp. 485-487.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.